Get the Latest News Updates

For the second time, Pfizer CEO tests positive for COVID.

Pfizer Inc CEO Albert Bourla said on Saturday that he had tested positive for COVID-19.”I’m feeling good and free of symptoms,” Bourla stated in a statement.Bourla, 60, contacted COVID in August and began a course of the company’s oral COVID-19 antiviral medication, Paxlovid.Paxlovid is an antiviral drug intended to treat high-risk patients, such as the elderly.

Pfizer and its German partner BioNTech provided Bourla with four doses of the COVID vaccination.The CEO stated that he had not yet taken the new bivalent booster.The novel bivalent shots, developed by Moderna and a team from Pfizer and BioNTech, are aimed at the BA.5 and BA.4 Omicron subvariants, which account for 84.8% and 1.8% of the total, respectively.

, based on the most recent data, of all circulating variants in the United States.”I haven’t had the new bivalent booster yet because I followed CDC instructions and waited three months since my previous COVID case in mid-August,” Bourla noted.

The FDA approved new booster doses targeting the dominant BA.4 and BA.5 Omicron subvariants from Pfizer and Moderna in August.

This week, the federal government said that over 25 million doses of the so-called bivalent shots had been distributed. As manufacture of the Moderna vaccine ramps up, this was largely made up of the Pfizer/BioNTech vaccine.